HSBC Holdings
APLS

HSBC Holdings’s Apellis Pharmaceuticals APLS Stock Holding History

HSBC Holdings’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$239K Buy
+5,944
New +$128K ﹤0.01% 2540
2025
Q4 		– Sell
-15,025
Closed -$345K – 2921
2025
Q3 		$345K Sell
15,025
-42,873
-74% -$1,000K ﹤0.01% 2277
2025
Q2 		$1M Buy
57,898
+32,899
+132% +$609K ﹤0.01% 1798
2025
Q1 		$552K Sell
24,999
-102,829
-80% -$2.84M ﹤0.01% 2024
2024
Q4 		$4.08M Buy
127,828
+9,341
+8% +$281K ﹤0.01% 1209
2024
Q3 		$3.41M Buy
118,487
+83,563
+239% +$3.09M ﹤0.01% 1241
2024
Q2 		$1.34M Sell
34,924
-63,626
-65% -$2.88M ﹤0.01% 1548
2024
Q1 		$5.79M Buy
+98,550
New +$6.28M ﹤0.01% 1052
2023
Q4 		– Sell
-50,544
Closed -$1.96M – 2716
2023
Q3 		$1.96M Buy
+50,544
New +$2.22M ﹤0.01% 1459
2023
Q2 		– Sell
-17,530
Closed -$1.17M – 2557
2023
Q1 		$1.17M Buy
+17,530
New +$1.01M ﹤0.01% 1704
2022
Q3 		– Sell
-10,887
Closed -$497K – 2919
2022
Q2 		$497K Buy
10,887
+996
+10% +$45.4K ﹤0.01% 2337
2022
Q1 		$504K Buy
9,891
+5,290
+115% +$234K ﹤0.01% 2415
2021
Q4 		$219K Buy
+4,601
New +$181K ﹤0.01% 2988
2021
Q3 		– Sell
-3,701
Closed -$236K – 2974
2021
Q2 		$236K Buy
+3,701
New +$191K ﹤0.01% 2671
2020
Q3 		– Sell
-7,580
Closed -$248K – 2714
2020
Q2 		$248K Buy
+7,580
New +$243K ﹤0.01% 2226

Other funds holding APLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

HSBC Holdings's APLS Position: Q1 2026 in Review

HSBC Holdings opened a new position in Apellis Pharmaceuticals (APLS) in Q1 2026: 5,944 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #2540 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in APLS as recently as Q3 2025.

HSBC Holdings first reported a position in APLS in Q2 2020 and has held it in 15 quarters since. The position peaked at $5.79M in Q1 2024. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • HSBC Holdings held 5,944 shares of Apellis Pharmaceuticals worth $239K as of Q1 2026.
  • Apellis Pharmaceuticals was a new HSBC Holdings position in Q1 2026.
  • Apellis Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2540 holding.
  • HSBC Holdings first reported a position in Apellis Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
  • HSBC Holdings's Apellis Pharmaceuticals position peaked at $5.79M in Q1 2024.
  • 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.